Northwestern Mutual Wealth Management
PPBT

Northwestern Mutual Wealth Management’s Purple Biotech PPBT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32 Sell
8
-1
-11% -$5 ﹤0.01% 4052
2025
Q4 		$56 Hold
9
– – ﹤0.01% 3898
2025
Q3 		$49 Hold
9
– – ﹤0.01% 3732
2025
Q2 		$199 Hold
9
– – ﹤0.01% 3511
2025
Q1 		$226 Buy
+9
New +$288 ﹤0.01% 3445
2024
Q2 		– Hold
0
– -$3 – 3746
2024
Q1 		– Hold
0
– – – 3546

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Northwestern Mutual Wealth Management's PPBT Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Purple Biotech (PPBT) stake by 11% in Q1 2026, selling an estimated $5 and leaving 8 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #4052.

Northwestern Mutual Wealth Management first reported a position in PPBT in Q1 2025 and has held it in 5 quarters since. The position peaked at $226 in Q1 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Northwestern Mutual Wealth Management held 8 shares of Purple Biotech worth $32 as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 1 Purple Biotech share in Q1 2026, an estimated $5.
  • Purple Biotech made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4052 holding.
  • Northwestern Mutual Wealth Management first reported a position in Purple Biotech in Q1 2025 and has held it in 5 quarters since.
  • Northwestern Mutual Wealth Management's Purple Biotech position peaked at $226 in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.